{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:45:13Z","timestamp":1791884713045,"version":"4.3.4"},"reference-count":70,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiovascular disease remains the leading cause of death in patients receiving maintenance dialysis, whereas conventional thrice-weekly hemodialysis was developed primarily around small-solute clearance rather than cardiovascular protection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This narrative review examines dialysis strategies intended to mitigate cardiovascular stress arising from cyclic volume loading, rapid ultrafiltration, electrolyte shifts, myocardial stunning, vascular stiffness, inflammation and anemia, middle-molecule toxicity, loss of residual kidney function, and the long interdialytic interval.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Evidence synthesis<\/jats:title>\n                    <jats:p>Randomized trials and individual-patient-data meta-analyses have evaluated high-dose online hemodiafiltration, with some studies reporting improved survival compared with conventional hemodialysis. Results have varied across trials, and questions remain regarding treatment delivery, generalizability, and the mechanisms underlying the observed effects. More frequent, nocturnal, and long-duration dialysis schedules improve intermediate endpoints, including left ventricular mass, blood pressure, phosphate control, ultrafiltration intensity, and treatment tolerance, but hard-outcome evidence remains limited. Expanded hemodialysis with medium cut-off membranes improves clearance of larger middle molecules, although cardiovascular benefit is unproven. Individualized dialysate potassium and sodium prescriptions are physiologically compelling precision-dialysis approaches targeting arrhythmia risk, volume overload, blood pressure, and cardiac remodeling, but definitive endpoint trials are needed. Incremental dialysis might preserve residual kidney function in selected incident patients, but cardiovascular benefit remains vulnerable to selection bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Future trials should be multicenter, phenotype-enriched, mechanism-specific, adequately powered, and endpoint-adjudicated. Endpoints should match the intervention: rhythm monitoring for potassium strategies, cardiac magnetic resonance and objective volume assessment for sodium or volume interventions, and integrated inflammatory, nutritional, vascular, and clinical outcomes for membrane-based approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ndt\/gfag223","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:33:36Z","timestamp":1790681616000},"source":"Crossref","is-referenced-by-count":0,"title":["Beyond Kt\/V: redefining dialysis adequacy as targeted cardiovascular risk reduction"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6616-1996","authenticated-orcid":false,"given":"Carmine","family":"Zoccali","sequence":"first","affiliation":[{"name":"Renal Research Institute , New York, NY ,","place":["USA"]},{"name":"Institute of Molecular Biology and Genetics , Ariano Irpino ,","place":["Italy"]},{"name":"Associazione Ipertensione Nefrologia Trapianto Renale (IPNET) , Reggio Calabria ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Strippoli","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health, The University of Sydney , Sydney ,","place":["Australia"]},{"name":"Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro , Bari ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Locatelli","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, (Past Director), ASST Lecco , Lecco ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mallamaci","sequence":"additional","affiliation":[{"name":"Associazione Ipertensione Nefrologia Trapianto Renale (IPNET) , Reggio Calabria ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Len","family":"Usyat","sequence":"additional","affiliation":[{"name":"Fresenius Medical Care, Global Medical Office , Waltham, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Stuard","sequence":"additional","affiliation":[{"name":"Fresenius Medical Care, Global Medical Office , Palazzo Pignano ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"2026101304522908300_bib1","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMoa021583","article-title":"Effect of dialysis dose and membrane flux in maintenance hemodialysis","volume":"347","author":"Eknoyan","year":"2002","journal-title":"N Engl J Med"},{"key":"2026101304522908300_bib2","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1001\/jama.2009.1488","article-title":"Cardiovascular and noncardiovascular mortality among patients starting dialysis","volume":"302","author":"de\u00a0Jager","year":"2009","journal-title":"JAMA"},{"key":"2026101304522908300_bib3","doi-asserted-by":"publisher","DOI":"10.1111\/joim.70127","article-title":"Sudden death in CKD and dialysis. From descriptive epidemiology to mechanism-driven prevention","author":"Zoccali","year":"2026","journal-title":"J Intern Med"},{"key":"2026101304522908300_bib4","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/ki.1995.22","article-title":"Clinical and echocardiographic disease in patients starting end-stage renal disease therapy","volume":"47","author":"Foley","year":"1995","journal-title":"Kidney Int"},{"key":"2026101304522908300_bib5","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780199592548.001.0001","volume-title":"Oxford textbook of clinical nephrology","author":"Zoccali","year":"2015","edition":"4th edn."},{"key":"2026101304522908300_bib6","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1093\/ndt\/gfs416","article-title":"Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis","volume":"27","author":"Zimmerman","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2026101304522908300_bib7","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1161\/hy1001.096358","article-title":"Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease","volume":"38","author":"Blacher","year":"2001","journal-title":"Hypertension"},{"key":"2026101304522908300_bib8","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in cardiovascular disease, high blood pressure research, Clinical cardiology, and epidemiology and prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"2026101304522908300_bib9","doi-asserted-by":"publisher","first-page":"914","DOI":"10.2215\/CJN.03900808","article-title":"Hemodialysis-induced cardiac injury: determinants and associated outcomes","volume":"4","author":"Burton","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026101304522908300_bib10","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1056\/NEJMoa1103313","article-title":"Long interdialytic interval and mortality among patients receiving hemodialysis","volume":"365","author":"Foley","year":"2011","journal-title":"N Engl J Med"},{"key":"2026101304522908300_bib11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/ki.2010.315","article-title":"Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics","volume":"79","author":"Pun","year":"2011","journal-title":"Kidney Int"},{"key":"2026101304522908300_bib12","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/hc1102.105261","article-title":"Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease","volume":"105","author":"Zoccali","year":"2002","journal-title":"Circulation"},{"key":"2026101304522908300_bib13","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2026101304522908300_bib14","doi-asserted-by":"publisher","first-page":"iii35","DOI":"10.1093\/ndt\/gfy175","article-title":"Chronic inflammation in end-stage renal disease and dialysis","volume":"33","author":"Cobo","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2026101304522908300_bib15","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/ndt\/gfg074","article-title":"Oxidative stress in end-stage renal disease: an emerging threat to patient outcome","volume":"18","author":"Locatelli","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"2026101304522908300_bib16","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1016\/j.healun.2022.01.336","article-title":"Pulmonary hypertension in the setting of hemodialysis arteriovenous fistulas: natural history and outcomes","volume":"41","author":"Bae","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"2026101304522908300_bib17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2 and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026101304522908300_bib18","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1515\/med-2020-0203","article-title":"72 hour Holter monitoring, 7 day Holter monitoring, and 30 day intermittent patient-activated heart rhythm recording in detecting arrhythmias in cryptogenic stroke patients free from arrhythmia in a screening 24\u2009h Holter","volume":"15","author":"Ku\u0142ach","year":"2020","journal-title":"Open Med"},{"key":"2026101304522908300_bib19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000167013","article-title":"Importance of whole-body bioimpedance spectroscopy for the management of fluid balance","volume":"27","author":"Wabel","year":"2009","journal-title":"Blood Purif"},{"key":"2026101304522908300_bib20","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.kint.2017.01.013","article-title":"Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly","volume":"91","author":"Morena","year":"2017","journal-title":"Kidney Int"},{"key":"2026101304522908300_bib21","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1093\/ndt\/gfs530","article-title":"Online haemodiafiltration: definition, dose quantification and safety revisited","volume":"28","author":"Tattersall","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2026101304522908300_bib22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ki.2014.9","article-title":"Online hemodiafiltration reduces systemic inflammation compared to low-flux hemodialysis","volume":"86","author":"den\u00a0Hoedt","year":"2014","journal-title":"Kidney Int"},{"key":"2026101304522908300_bib23","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.4049\/jimmunol.1800747","article-title":"Online hemodiafiltration inhibits inflammation-related endothelial dysfunction and vascular calcification of uremic patients modulating miR-223 expression in plasma extracellular vesicles","volume":"202","author":"Cavallari","year":"2019","journal-title":"J Immunol"},{"key":"2026101304522908300_bib24","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1681\/ASN.2010030280","article-title":"Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD","volume":"21","author":"Locatelli","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2026101304522908300_bib25","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1681\/ASN.2012080875","article-title":"High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients","volume":"24","author":"Maduell","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2026101304522908300_bib26","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1681\/ASN.2011121140","article-title":"Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes","volume":"23","author":"Grooteman","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2026101304522908300_bib27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/ndt\/gfs407","article-title":"Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study","volume":"28","author":"Ok","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2026101304522908300_bib28","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/ndt\/gfv349","article-title":"Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials","volume":"31","author":"Peters","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"2026101304522908300_bib29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/ndt\/gfw310","article-title":"Performance of hemodialysis with novel medium cut-off dialyzers","volume":"32","author":"Kirsch","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2026101304522908300_bib30","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.2215\/CJN.01210120","article-title":"Efficacy and safety of expanded hemodialysis with the Theranova 400 dialyzer: a randomized controlled trial","volume":"15","author":"Weiner","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026101304522908300_bib31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/toxins10010033","article-title":"Biochemical and clinical impact of organic uremic retention solutes: a comprehensive update","volume":"10","author":"Vanholder","year":"2018","journal-title":"Toxins"},{"key":"2026101304522908300_bib32","doi-asserted-by":"publisher","first-page":"e0169024","DOI":"10.1371\/journal.pone.0169024","article-title":"Medium cut-off (MCO) membranes reduce inflammation in chronic dialysis patients\u2014A randomized controlled clinical trial","volume":"12","author":"Zickler","year":"2017","journal-title":"PLoS One"},{"key":"2026101304522908300_bib33","doi-asserted-by":"publisher","first-page":"10807","DOI":"10.1038\/s41598-021-90311-6","article-title":"Cardiovascular risk comparison between expanded hemodialysis using Theranova and online hemodiafiltration (CARTOON): a multicenter randomized controlled trial","volume":"11","author":"Lee","year":"2021","journal-title":"Sci Rep"},{"key":"2026101304522908300_bib34","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1093\/ndt\/gfx241","article-title":"Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients","volume":"33","author":"Brunelli","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2026101304522908300_bib35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/hdi.12195","article-title":"Potassium kinetics during hemodialysis","volume":"19","author":"Agar","year":"2015","journal-title":"Hemodial Int"},{"key":"2026101304522908300_bib36","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.kint.2016.01.010","article-title":"The choice of dialysate bicarbonate: do different concentrations make a difference?","volume":"89","author":"Basile","year":"2016","journal-title":"Kidney Int"},{"key":"2026101304522908300_bib37","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1053\/j.ajkd.2016.09.015","article-title":"Dialysate potassium, serum potassium, mortality, and arrhythmia events in hemodialysis: results from the dialysis outcomes and practice patterns study (DOPPS)","volume":"69","author":"Karaboyas","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"2026101304522908300_bib38","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.kint.2017.11.019","article-title":"Primary outcomes of the monitoring in dialysis study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle","volume":"93","author":"Roy-Chaudhury","year":"2018","journal-title":"Kidney Int"},{"key":"2026101304522908300_bib39","doi-asserted-by":"publisher","first-page":"e12447","DOI":"10.1111\/anec.12447","article-title":"2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring\/telemetry","volume":"22","author":"Steinberg","year":"2017","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2026101304522908300_bib40","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/ki.1996.356","article-title":"Effect of a new model of hemodialysis potassium removal on the control of ventricular arrhythmias","volume":"50","author":"Redaelli","year":"1996","journal-title":"Kidney Int"},{"key":"2026101304522908300_bib41","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.kint.2025.07.018","article-title":"Where next for potassium binders in hemodialysis?","volume":"108","author":"Ravi","year":"2025","journal-title":"Kidney Int"},{"key":"2026101304522908300_bib42","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.kint.2025.06.016","article-title":"The randomized DIALIZE-outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis","volume":"108","author":"Fishbane","year":"2025","journal-title":"Kidney Int"},{"key":"2026101304522908300_bib43","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1016\/j.ekir.2024.08.005","article-title":"Randomized trial of patiromer on efficacy to reduce episodic hyperkalemia in patients with ESKD treated with hemodialysis","volume":"9","author":"Middleton","year":"2024","journal-title":"Kidney Int Rep"},{"key":"2026101304522908300_bib44","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.kint.2024.10.010","article-title":"Effects of dialysate potassium concentration of 3.0 mmol\/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol\/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia","volume":"107","author":"Charytan","year":"2025","journal-title":"Kidney Int"},{"key":"2026101304522908300_bib45","doi-asserted-by":"publisher","first-page":"CD011204","DOI":"10.1002\/14651858.CD011204.PUB2","article-title":"Low dialysate sodium levels for chronic haemodialysis","volume":"1","author":"Dunlop","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2026101304522908300_bib46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2215\/CJN.05440611","article-title":"Dialysate sodium concentration and the association with interdialytic weight gain, hospitalization, and mortality","volume":"7","author":"Hecking","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026101304522908300_bib47","doi-asserted-by":"publisher","first-page":"522","DOI":"10.2215\/CJN.03360807","article-title":"Revisiting the dialysate sodium prescription as a tool for better blood pressure and interdialytic weight gain management in hemodialysis patients","volume":"3","author":"Santos","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026101304522908300_bib48","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1093\/ndt\/gfaa182","article-title":"Volume overload in hemodialysis: diagnosis, cardiovascular consequences, and management","volume":"36","author":"Loutradis","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"2026101304522908300_bib49","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.kint.2020.01.046","article-title":"Blood pressure and volume management in dialysis: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"97","author":"Flythe","year":"2020","journal-title":"Kidney Int"},{"key":"2026101304522908300_bib50","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1111\/j.1523-1755.2004.00876.x","article-title":"Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients","volume":"66","author":"De\u00a0Paula","year":"2004","journal-title":"Kidney Int"},{"key":"2026101304522908300_bib51","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1681\/ASN.2019090877","article-title":"Effect of low-sodium versus conventional sodium dialysate on left ventricular mass in home and self-care satellite facility hemodialysis patients: a randomized clinical trial","volume":"31","author":"Marshall","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"2026101304522908300_bib52","doi-asserted-by":"publisher","first-page":"CD011204","DOI":"10.1002\/14651858.CD011204.PUB3","article-title":"Low dialysate sodium levels for chronic haemodialysis","volume":"11","author":"Marshall","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"2026101304522908300_bib53","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.2215\/CJN.0000000000000521","article-title":"Antihypertensive drug treatment and the risk for intrahemodialysis hypotension","volume":"19","author":"Zoccali","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026101304522908300_bib54","doi-asserted-by":"publisher","first-page":"188","DOI":"10.23736\/S0031-0808.17.03299-2","article-title":"Incremental and infrequent hemodialysis: a new paradigm for both dialysis initiation and conservative management","volume":"59","author":"Rhee","year":"2017","journal-title":"Panminerva Med"},{"key":"2026101304522908300_bib55","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1053\/j.ajkd.2009.02.012","article-title":"The importance of residual kidney function for patients on dialysis: a critical review","volume":"53","author":"Perl","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2026101304522908300_bib56","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12882-019-1527-3","article-title":"Renal Association Clinical Practice Guideline on haemodialysis","volume":"20","author":"Ashby","year":"2019","journal-title":"BMC Nephrol"},{"key":"2026101304522908300_bib57","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1053\/j.ajkd.2016.01.008","article-title":"Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: a cohort study","volume":"68","author":"Obi","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2026101304522908300_bib58","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.kint.2019.01.017","article-title":"Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"96","author":"Chan","year":"2019","journal-title":"Kidney Int"},{"key":"2026101304522908300_bib59","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2147\/IJNRD.S286947","article-title":"Incremental hemodialysis: what we know so far","volume":"15","author":"Soi","year":"2022","journal-title":"IJNRD"},{"key":"2026101304522908300_bib60","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/ckj\/sfy082","article-title":"Residual renal function in incremental dialysis","volume":"11","author":"Tattersall","year":"2018","journal-title":"Clin Kidney J"},{"key":"2026101304522908300_bib61","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/MNH.0000000000000174","article-title":"Rapid ultrafiltration rates and outcomes among hemodialysis patients: re-examining the evidence base","volume":"24","author":"Assimon","year":"2015","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2026101304522908300_bib62","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1161\/CIRCIMAGING.111.969923","article-title":"Determinants of left ventricular mass in patients on hemodialysis: the frequent hemodialysis network (FHN) trials","volume":"5","author":"Chan","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026101304522908300_bib63","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1001\/jama.298.11.1291","article-title":"Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial","volume":"298","author":"Culleton","year":"2007","journal-title":"JAMA"},{"key":"2026101304522908300_bib64","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1056\/NEJMoa1001593","article-title":"In-center hemodialysis six times per week versus three times per week","volume":"363","author":"Chertow","year":"2010","journal-title":"N Engl J Med"},{"key":"2026101304522908300_bib65","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/ki.2011.213","article-title":"The effects of frequent nocturnal home hemodialysis: the frequent Hemodialysis Network Nocturnal Trial","volume":"80","author":"Rocco","year":"2011","journal-title":"Kidney Int"},{"key":"2026101304522908300_bib66","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1681\/ASN.2012060595","article-title":"Risk of vascular access complications with frequent hemodialysis","volume":"24","author":"Suri","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2026101304522908300_bib67","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/ki.2012.457","article-title":"Effect of frequent hemodialysis on residual kidney function","volume":"83","author":"Daugirdas","year":"2013","journal-title":"Kidney Int"},{"key":"2026101304522908300_bib68","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1056\/NEJMoa2304820","article-title":"Effect of hemodiafiltration or hemodialysis on mortality in kidney failure","volume":"389","author":"Blankestijn","year":"2023","journal-title":"N Engl J Med"},{"key":"2026101304522908300_bib69","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1016\/S0140-6736(24)01859-2","article-title":"Haemodiafiltration versus haemodialysis for kidney failure: an individual patient data meta-analysis of randomised controlled trials","volume":"404","author":"Vernooij","year":"2024","journal-title":"Lancet"},{"key":"2026101304522908300_bib70","doi-asserted-by":"publisher","first-page":"20543581211067090","DOI":"10.1177\/20543581211067090","article-title":"Effects of medium cut-off versus high-flux hemodialysis membranes on biomarkers: a systematic review and meta-analysis","volume":"9","author":"Kandi","year":"2022","journal-title":"Can J Kidney Health Dis"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag223\/71518995\/gfag223.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag223\/71518995\/gfag223.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:52:32Z","timestamp":1791881552000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article\/doi\/10.1093\/ndt\/gfag223\/8853757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":70,"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfag223","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"gfag223"}}